Alamar Capital Management LLC Acquires 6,950 Shares of Tenet Healthcare Corporation $THC

Key Points

• Alamar Capital Management increased its Tenet Healthcare stake by 62.5% in the second quarter, purchasing 6,950 additional shares and bringing its holdings to 18,062 shares valued at about $3.38 million. Institutional investors own 95.44% of THC.
• Tenet reported quarterly earnings of $6.12 per share, surpassing the $4.26 consensus estimate, while revenue rose 6.8% year over year to $6.04 billion. The company issued fiscal 2026 EPS guidance of $20.30–$21.69.
• Analysts maintain a positive outlook, with a consensus “Buy” rating and average price target of $273.00. However, insiders sold roughly $29.0 million of shares during the past quarter, including sales by the CEO and a director.

Alamar Capital Management LLC grew its stake in shares of Tenet Healthcare Corporation (NYSE:THC - Free Report) by 62.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 18,062 shares of the company's stock after purchasing an additional 6,950 shares during the period. Tenet Healthcare makes up 1.7% of Alamar Capital Management LLC's investment portfolio, making the stock its 11th biggest holding. Alamar Capital Management LLC's holdings in Tenet Healthcare were worth $3,379,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in THC. Price T Rowe Associates Inc. MD raised its position in shares of Tenet Healthcare by 1.6% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,490,350 shares of the company's stock worth $1,488,484,000 after purchasing an additional 119,809 shares during the period. Boston Partners lifted its stake in shares of Tenet Healthcare by 15.7% in the fourth quarter. Boston Partners now owns 3,642,136 shares of the company's stock valued at $723,804,000 after buying an additional 494,581 shares in the last quarter. AQR Capital Management LLC increased its position in shares of Tenet Healthcare by 20.3% during the fourth quarter. AQR Capital Management LLC now owns 2,256,539 shares of the company's stock worth $448,419,000 after acquiring an additional 380,116 shares in the last quarter. Ameriprise Financial Inc. raised its holdings in shares of Tenet Healthcare by 8.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company's stock worth $373,020,000 after acquiring an additional 157,109 shares during the last quarter. Finally, Norges Bank bought a new position in Tenet Healthcare in the 4th quarter valued at about $248,494,000. 95.44% of the stock is owned by institutional investors.

Tenet Healthcare Trading Down 2.7%

NYSE:THC opened at $258.79 on Thursday. The firm's 50 day moving average is $234.93 and its 200 day moving average is $210.62. Tenet Healthcare Corporation has a 12 month low of $157.58 and a 12 month high of $283.05. The stock has a market capitalization of $20.84 billion, a PE ratio of 9.98, a price-to-earnings-growth ratio of 1.01 and a beta of 1.23. The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00.

Tenet Healthcare (NYSE:THC - Get Free Report) last posted its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, topping the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The company had revenue of $6.04 billion during the quarter, compared to the consensus estimate of $5.43 billion. During the same quarter in the prior year, the company earned $4.02 EPS. The firm's quarterly revenue was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Sell-side analysts expect that Tenet Healthcare Corporation will post 21.04 earnings per share for the current year.

Analyst Upgrades and Downgrades

THC has been the subject of several recent research reports. Piper Sandler set a $308.00 price target on Tenet Healthcare in a report on Monday, July 27th. The Goldman Sachs Group reiterated a "buy" rating and issued a $305.00 target price on shares of Tenet Healthcare in a research note on Tuesday, July 28th. Guggenheim raised their price target on shares of Tenet Healthcare from $242.00 to $283.00 and gave the company a "buy" rating in a research report on Tuesday, July 28th. Wall Street Zen raised shares of Tenet Healthcare from a "buy" rating to a "strong-buy" rating in a research report on Sunday, August 23rd. Finally, Mizuho set a $290.00 target price on shares of Tenet Healthcare in a research report on Monday, August 10th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Buy" and an average target price of $273.00.

Insiders Place Their Bets

In related news, Director Tammy Romo sold 4,922 shares of the business's stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $264.15, for a total transaction of $1,300,146.30. Following the completion of the transaction, the director owned 30,784 shares of the company's stock, valued at approximately $8,131,593.60. The trade was a 13.78% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Saumya Sutaria sold 50,000 shares of the stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $278.71, for a total transaction of $13,935,500.00. Following the completion of the sale, the chief executive officer owned 483,564 shares in the company, valued at $134,774,122.44. This represents a 9.37% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 108,037 shares of company stock worth $28,965,972 over the last quarter. Insiders own 0.97% of the company's stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.